(BAXTER) GLUCOSE 5% w/v Intravenous Infusion

What is (BAXTER) GLUCOSE 5% w/v

BAXTER GLUCOSE 5% w/v is a sterile, non-pyrogenic intravenous solution composed of 5% glucose (dextrose) in water. It is supplied in 100 mL Viaflo plastic infusion bags, packed in cartons of 60 units. This solution serves multiple medical purposes and is widely used in hospital and clinical settings.

• Provides a source of calories in the form of carbohydrates (200 kcal/L)
• Used for fluid replenishment and maintenance of hydration
• Acts as a carrier for compatible intravenous medications
• Suitable for patients unable to eat or drink temporarily

BAXTER GLUCOSE 5% w/v is free of electrolytes and is considered an isotonic solution, making it particularly useful in cases requiring volume expansion without altering serum sodium or potassium levels. It is widely used in internal medicine, intensive care, and perioperative management.

How to use (BAXTER) GLUCOSE 5% w/v

BAXTER GLUCOSE 5% w/v is intended for intravenous (IV) administration only and should be used under the supervision of healthcare professionals.

• Preparation: Inspect the solution and container before use. Do not use if the solution is cloudy, discolored, or contains particulate matter.
• Administration: Administer via a sterile IV set using aseptic technique. The bag should be connected to an appropriate infusion line.
• Infusion rate: Should be determined based on patient-specific needs such as age, weight, fluid balance, and caloric requirement.
• Monitoring: Vital signs, serum glucose levels, and fluid status should be closely monitored during administration.
• Mixing with drugs: Can be used as a diluent for compatible IV medications. Always confirm compatibility before mixing.

This solution should not be administered concurrently with blood products through the same IV set to avoid hemolysis. It is not suitable for use in patients requiring electrolyte replacement unless additional electrolytes are added.

Mode of Action (BAXTER) GLUCOSE 5% w/v

The active ingredient, glucose (also known as dextrose), is a primary energy source for body tissues. Upon intravenous administration, BAXTER GLUCOSE 5% w/v delivers carbohydrates directly into the bloodstream for immediate cellular use.

• Energy source: Glucose provides rapid energy for cells, especially important for the brain, red blood cells, and muscles.
• Glycogen storage: Excess glucose is stored in the liver and muscles as glycogen for future energy use.
• Protein sparing effect: When sufficient carbohydrates are provided, protein breakdown is minimized, preserving lean body mass.
• Fluid replacement: Provides free water that helps correct dehydration and maintain hydration without affecting sodium balance.

Glucose is taken up into cells with the help of insulin. It undergoes glycolysis and the citric acid cycle to produce ATP, the energy currency of cells. This mechanism is essential for cellular function, particularly in patients under metabolic stress or fasting conditions.

(BAXTER) GLUCOSE 5% w/v Interactions (BAXTER) GLUCOSE 5% w/v

p> Though BAXTER GLUCOSE 5% w/v is a basic supportive therapy, interactions may occur when combined with specific drugs or conditions that influence carbohydrate metabolism or fluid-electrolyte balance.

• Insulin: Co-administration can cause hypoglycemia due to increased cellular glucose uptake. Dosages must be adjusted accordingly.
• Corticosteroids or Diuretics: These may raise blood glucose levels or alter fluid status, requiring close monitoring.
• Blood Products: Should not be infused through the same line to avoid hemolysis or coagulation.
• IV Medications: May be mixed with compatible drugs; however, precipitation or incompatibility can occur. Always check compatibility references before admixture.

Patients on anti-diabetic agents, diuretics, or corticosteroids should be monitored closely to prevent complications such as hyperglycemia or fluid overload.

Dosage of (BAXTER) GLUCOSE 5% w/v

Dosage and infusion rate should be tailored individually based on patient needs, clinical condition, and intended use (fluid replacement or caloric supplementation).

• Adults: Typically 500 mL to 3,000 mL per day, adjusted to metabolic and fluid requirements.
• Pediatric patients: Dosage depends on age, weight, and clinical status, usually 100–200 mL/kg/day or as directed by a physician.
• Maximum rate: Should not exceed the patient’s glucose oxidation capacity, generally 4–5 mg/kg/min for adults.
• Monitoring: Regular monitoring of blood glucose, serum electrolytes, and fluid balance is crucial.

Special consideration is required in patients with diabetes, renal impairment, or cardiac conditions, as over-infusion can lead to complications such as fluid overload or glucose intolerance.

Possible side effects of (BAXTER) GLUCOSE 5% w/v

BAXTER GLUCOSE 5% w/v is usually well-tolerated when administered correctly. However, side effects may occur, particularly with prolonged or high-volume use.

• Local reactions: Pain, redness, or swelling at the infusion site
• Metabolic effects:
  • Hyperglycemia (especially in diabetic patients)
  • Electrolyte disturbances such as hyponatremia or hypokalemia
• Systemic effects:
  • Fluid overload, especially in renal or heart failure patients
  • Osmotic diuresis in high glucose concentrations
• Rare effects:
  • Thrombophlebitis at the infusion site
  • Allergic reactions (rare)

If any adverse reaction occurs, the infusion should be stopped immediately, and appropriate clinical measures should be taken.

(BAXTER) GLUCOSE 5% w/v Contraindications (BAXTER) GLUCOSE 5% w/v

There are several clinical scenarios in which BAXTER GLUCOSE 5% w/v should be avoided due to the risk of complications.

• Severe hyperglycemia: Administration may worsen glucose control.
• Intracranial or intraspinal hemorrhage: Hypotonic fluids like glucose may increase cerebral edema.
• Uncontrolled diabetes mellitus: Can lead to dangerous hyperglycemia without adequate insulin coverage.
• Severe renal impairment or anuria: Increased risk of fluid overload and electrolyte imbalances.
• Allergy to corn derivatives: Glucose is often derived from corn starch.

Caution is advised in neonates, elderly patients, or individuals with liver dysfunction. Use only under medical supervision with close monitoring.

Storage of (BAXTER) GLUCOSE 5% w/v

Proper storage of BAXTER GLUCOSE 5% w/v is essential to maintain sterility and chemical integrity.

• Temperature: Store at 15°C to 25°C (59°F to 77°F). Avoid freezing, as it may compromise container integrity.
• Light sensitivity: Keep away from direct sunlight and strong artificial light.
• Integrity check: Do not use if the bag is leaking, the seal is broken, or the solution is discolored or contains particulate matter.
• Post-opening: Once the bag is opened, use immediately. Discard any unused portion to prevent contamination.
• Shelf life: Refer to the manufacturer's packaging for expiry date.

Storage must comply with institutional protocols for sterile IV fluids. Dispose of expired or unused bags in accordance with local regulations.